Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Diclofenac Sodium Topical from Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac Sodium Topical (Diclofenac sodium topical)

Snippet

SUPPL AP for DICLOFENAC SODIUM (DICLOFENAC SODIUM TOPICAL)